chartexchange

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer

GlobeNewswire Inc. | Sep 22, 2026 8:47 AM EDT

Strong pace of patient enrollment supports continued advancement toward regulatory milestones

Read original article